Hps Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 2.62 Cr
as on 29-12-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.35 Cr
as on 29-12-2024
- Revenue %
(FY 2020)
- Profit -19.76%
(FY 2020)
- Ebitda -19.87%
(FY 2020)
- Net Worth -0.25%
(FY 2020)
- Total Assets -0.00%
(FY 2020)
About Hps Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.62 Cr.
The company has closed loans amounting to ₹3.35 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vishnuvardhan Devireddy, Padma Duvvuri, and Mallikarjuna Venati serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC049581
- Company No.
049581
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hps Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnuvardhan Devireddy  | Director | 05-Dec-2017 | Current |
| Padma Duvvuri | Director | 23-Mar-2006 | Current |
| Mallikarjuna Venati | Director | 23-Mar-2006 | Current |
Financial Performance of Hps Laboratories.
Hps Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 19.76% decrease in profit. The company's net worth dipped by a decrease of 0.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hps Laboratories?
In 2020, Hps Laboratories had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Konar Organics LimitedActive 36 years 11 monthsVishnuvardhan Devireddy, Padma Duvvuri and 1 more are mutual person
Popular Molecules Private LimitedActive 9 years 6 monthsVishnuvardhan Devireddy and Mallikarjuna Venati are mutual person
- Norrish Laboratories Private LimitedActive 12 years 28 days
Vishnuvardhan Devireddy, Padma Duvvuri and 1 more are mutual person
- Phanicare Pharmaceuticals Private LimitedActive 21 years 3 months
Vishnuvardhan Devireddy, Padma Duvvuri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 02 Mar 2013 | ₹3.35 Cr | Satisfied |
How Many Employees Work at Hps Laboratories?
Unlock and access historical data on people associated with Hps Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hps Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hps Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
